908 Devices CFO gets RSUs, options; sells shares
908 Devices Inc. Chief Financial Officer Joseph H. Griffith IV reported a mix of equity grants, vesting and a tax-related sale.
Rhea-AI Filing Summary
908 Devices Inc. Chief Financial Officer Joseph H. Griffith IV reported a mix of equity grants, vesting and a tax-related sale. On February 1, 2026, several tranches of RSUs vested and settled into 5,102, 10,306, 11,260 and 43,473 shares of common stock. On February 2, 2026, he received 121,164 new RSUs and a stock option for 52,967 shares with a $6.19 exercise price. That same day, he sold 23,175 shares at a weighted average of $6.18 solely to cover tax withholding triggered by the RSU vesting, under a required “sell to cover” arrangement. After these transactions, he directly held 139,896 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
11 txns
Insider
Griffith Joseph H. IV
Role
Chief Financial Officer
Sold
23,175 shs ($143K)
Approx. gross sale proceeds
$143K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 121,164 | $0.00 | $0.00 |
| Grant/Award | Stock Option (option to buy) | 52,967 | $0.00 | $0.00 |
| Sale | Common Stock | 23,175 | $6.18 | $143K |
| Exercise | Restricted Stock Units | 5,102 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 10,306 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 11,260 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 43,473 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,102 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,306 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,260 | $0.00 | $0.00 |
| Exercise | Common Stock | 43,473 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 240,936 contracts (Direct);
Stock Option (option to buy) — 52,967 contracts (Direct);
Common Stock — 139,896 shares (Direct)
Footnotes (9)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
- F2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.105 to $6.35, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F5. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F6. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F7. The RSUs shall vest one-third on February 1, 2026, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F8. The RSUs shall vest one-third on February 1, 2027, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F9. One-third of the shares underlying the option become vested and exercisable on February 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date.
FAQ
What did 908 Devices (MASS) CFO Joseph H. Griffith IV report on this Form 4?
He reported RSU vesting into common shares, new equity awards, and a tax-related sale. Several RSU tranches converted into stock, he received additional RSUs and options, and sold shares only to cover withholding taxes after vesting.
How many new RSUs did the MASS CFO receive in the latest filing?
He received 121,164 new Restricted Stock Units (RSUs) on February 2, 2026. These RSUs vest one-third on February 1, 2027, with the remaining two-thirds vesting in two equal annual installments, subject to continued service, and have no expiration date.
What stock options were granted to the 908 Devices CFO in this Form 4?
He was granted a stock option for 52,967 shares at a $6.19 exercise price. One-third of these shares vest on February 1, 2027, with the remaining two-thirds vesting monthly over the following 24 months, contingent on continued service.
What is the CFO’s resulting common stock ownership after these transactions?
After the reported transactions, the CFO directly owned 139,896 shares of 908 Devices common stock. This figure reflects RSU settlements into shares, the new tax-related share sale, and all other reported changes in his direct non-derivative holdings.
How do the existing RSU awards for the MASS CFO vest over time?
Several RSU grants vest in four equal annual installments following February 1 of 2022, 2023 and 2024, contingent on continued service. Newer RSU awards vest one-third on specific future February 1 dates, with remaining portions vesting annually thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
